Lepe V et al. |
A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. |
2003 |
Arch Dermatol |
pmid:12756094
|
Plettenberg H et al. |
Childhood vitiligo and tacrolimus: immunomodulating treatment for an autoimmune disease. |
2003 |
Arch Dermatol |
pmid:12756103
|
Lübbe J et al. |
Adults with atopic dermatitis and herpes simplex and topical therapy with tacrolimus: what kind of prevention? |
2003 |
Arch Dermatol |
pmid:12756112
|
Allen A et al. |
Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. |
2001 |
Arch Dermatol |
pmid:11405764
|
Bigby M |
A thorough systematic review of treatments for atopic eczema. |
2001 |
Arch Dermatol |
pmid:11735714
|
Zonneveld IM et al. |
Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study. |
1998 |
Arch Dermatol |
pmid:9762021
|
Sagransky MJ et al. |
A randomized controlled pilot study of the effects of an extra office visit on adherence and outcomes in atopic dermatitis. |
2010 |
Arch Dermatol |
pmid:21173330
|
Laino L and DiCarlo A |
Palmoplantar pustular psoriasis: clinical and video thermographic evaluation before and after topical tacrolimus treatment. |
2011 |
Arch Dermatol |
pmid:21690553
|
Castelo-Soccio L et al. |
Induced lentiginosis with use of topical calcineurin inhibitors. |
2012 |
Arch Dermatol |
pmid:22710469
|
Kunstfeld R et al. |
Successful treatment of vulvar lichen sclerosus with topical tacrolimus. |
2003 |
Arch Dermatol |
pmid:12873877
|
Mackelfresh J et al. |
Combination therapy of doxycycline and topical tacrolimus for venous ulcers. |
2005 |
Arch Dermatol |
pmid:16301410
|
Yeh C et al. |
Effect of FK506 on functional recovery after facial nerve injury in the rat. |
2007 Sep-Oct |
Arch Facial Plast Surg |
pmid:17875826
|
Geramizadeh B et al. |
Post-transplantation lymphoproliferative disorder after liver transplantation: report of 5 cases among more than 550 liver transplants in Iran. |
2010 |
Arch Iran Med |
pmid:20804309
|
Dehghani SM et al. |
Tacrolimus related hypertrophic cardiomyopathy in liver transplant recipients. |
2010 |
Arch Iran Med |
pmid:20187665
|
Rybojad M |
[Atopic dermatitis]. |
2012 |
Arch Pediatr |
pmid:22796288
|
Monchaud C et al. |
[Long lasting side effects of immunosuppressants in children]. |
2007 |
Arch Pediatr |
pmid:17442546
|
Sánchez Ferreiro AV and Muñoz Bellido L |
[Tacrolimus in the treatment of atopic kerato-conjunctivitis]. |
2013 |
Arch Soc Esp Oftalmol |
pmid:23886369
|
RodrÃguez-AusÃn P et al. |
Topical tacrolimus 0.03% for the treatment of ocular psoriasis. |
2016 |
Arch Soc Esp Oftalmol |
pmid:27130870
|
Fryer JP et al. |
Bacterial translocation in a large-animal model of small-bowel transplantation. Portal vs systemic venous drainage and the effect of tacrolimus immunosuppression. |
1996 |
Arch Surg |
pmid:8546583
|
Harmon JV et al. |
Experimental short-term immunosuppression after bowel transplantation and donor-specific bone marrow infusion. |
2001 |
Arch Surg |
pmid:11448397
|
Echigo Y et al. |
Effects of cyclosporine and tacrolimus (FK 506) on acute pancreatitis in mice. |
1995 |
Arch Surg |
pmid:7528496
|
Freise CE et al. |
Excellent short-term results with steroid-free maintenance immunosuppression in low-risk simultaneous pancreas-kidney transplantation. |
2003 |
Arch Surg |
pmid:14557130
|
Johnson MW et al. |
Hepatitis C viral infection in liver transplantation. |
1996 |
Arch Surg |
pmid:8611094
|
Stötter H and Lotze MT |
Human lymphokine-activated killer cell activity. Role of IL-2, IL-4, and IL-7. |
1991 |
Arch Surg |
pmid:1726819
|
Wen H et al. |
Characterization of the binding sites for the interactions between FKBP12 and intracellular calcium release channels. |
2012 |
Arch. Biochem. Biophys. |
pmid:22100703
|
Vincent SH et al. |
In vitro metabolism of FK-506 in rat, rabbit, and human liver microsomes: identification of a major metabolite and of cytochrome P450 3A as the major enzymes responsible for its metabolism. |
1992 |
Arch. Biochem. Biophys. |
pmid:1373595
|
Yin M and Ochs RS |
Mechanism for the paradoxical inhibition and stimulation of calcineurin by the immunosuppresive drug tacrolimus (FK506). |
2003 |
Arch. Biochem. Biophys. |
pmid:14592464
|
Salowe SP and Hermes JD |
Competitive and slow-binding inhibition of calcineurin by drug x immunophilin complexes. |
1998 |
Arch. Biochem. Biophys. |
pmid:9675023
|
Tomono M et al. |
Inhibitors of calcineurin block expression of cyclins A and E induced by fibroblast growth factor in Swiss 3T3 fibroblasts. |
1998 |
Arch. Biochem. Biophys. |
pmid:9606972
|
Kakegawa T et al. |
Rapamycin induces binding activity to the terminal oligopyrimidine tract of ribosomal protein mRNA in rats. |
2002 |
Arch. Biochem. Biophys. |
pmid:12051685
|
Mukerjee N et al. |
Caspase-mediated proteolytic activation of calcineurin in thapsigargin-mediated apoptosis in SH-SY5Y neuroblastoma cells. |
2000 |
Arch. Biochem. Biophys. |
pmid:10898953
|
Borro JM et al. |
Long-term success of combined kidney-lung transplantation in a patient with cystic fibrosis. |
2013 |
Arch. Bronconeumol. |
pmid:23427867
|
Reig Mezquida JP et al. |
Thrombotic microangiopathy associated with tacrolimus in lung transplantation. |
2015 |
Arch. Bronconeumol. |
pmid:25138798
|
Zurbano F et al. |
Maternity and lung transplantation: cases in Spain. |
2012 |
Arch. Bronconeumol. |
pmid:22771003
|
Nishimuta K and Ito Y |
Effects of metronidazole and tinidazole ointments on models for inflammatory dermatitis in mice. |
2003 |
Arch. Dermatol. Res. |
pmid:12624780
|
Ito F et al. |
FK506 and cyclosporin A inhibit stem cell factor-dependent cell proliferation/survival, while inducing upregulation of c-kit expression in cells of the mast cell line MC/9. |
1999 |
Arch. Dermatol. Res. |
pmid:10367710
|
Lubaki LJ et al. |
Time-kinetic study of repigmentation in vitiligo patients by tacrolimus or pimecrolimus. |
2010 |
Arch. Dermatol. Res. |
pmid:19547993
|
Eberlein-König B et al. |
Modulation of histamine release in vitro by FK506 and interleukin-3 is determined by sequence of incubation. |
1997 |
Arch. Dermatol. Res. |
pmid:9373722
|
Hultsch T et al. |
Direct evidence that FK506 inhibition of FcepsilonRI-mediated exocytosis from RBL mast cells involves calcineurin. |
1998 |
Arch. Dermatol. Res. |
pmid:9681677
|
GarcÃa-GarcÃa B et al. |
Frosch' surface microscopy score for the assessment of steroid-induced atrophy. |
2014 |
Arch. Dermatol. Res. |
pmid:24402286
|
Paus R et al. |
Hair growth control by immunosuppression. |
1996 |
Arch. Dermatol. Res. |
pmid:8818191
|
Furukawa F et al. |
FK506: therapeutic effects on lupus dermatoses in autoimmune-prone MRL/Mp-lpr/lpr mice. |
1995 |
Arch. Dermatol. Res. |
pmid:7487142
|
Ockenfels HM et al. |
Cyclosporin A, FK506 and dithranol after tyrosine-specific protein phosphorylation in HaCaT keratinocytes. |
1995 |
Arch. Dermatol. Res. |
pmid:7541191
|
Yoon NY et al. |
Topical glucocorticoid or pimecrolimus treatment suppresses thymic stromal lymphopoietin-related allergic inflammatory mechanism in an oxazolone-induced atopic dermatitis murine model. |
2015 |
Arch. Dermatol. Res. |
pmid:25786383
|
Hofmann M et al. |
Validation of Dermaphot(®) for the assessment of steroid-induced skin atrophy. |
2013 |
Arch. Dermatol. Res. |
pmid:23242470
|
Toyota N et al. |
Effects of FK506 and cyclosporin A on proliferation, histamine release and phenotype of murine mast cells. |
1996 |
Arch. Dermatol. Res. |
pmid:8844128
|
Engelhart K et al. |
In vitro reproduction of clinical hallmarks of eczematous dermatitis in organotypic skin models. |
2005 |
Arch. Dermatol. Res. |
pmid:15952007
|
Hultsch T et al. |
Ascomycin macrolactam derivative SDZ ASM 981 inhibits the release of granule-associated mediators and of newly synthesized cytokines in RBL 2H3 mast cells in an immunophilin-dependent manner. |
1998 |
Arch. Dermatol. Res. |
pmid:9808344
|
Lauerma AI et al. |
Topical FK506: suppression of allergic and irritant contact dermatitis in the guinea pig. |
1994 |
Arch. Dermatol. Res. |
pmid:7526805
|
Allen BR et al. |
Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients. |
2003 |
Arch. Dis. Child. |
pmid:14612358
|
Deckers-Kocken JM and Pasmans SG |
Successful tacrolimus (FK506) therapy in a child with pyoderma gangrenosum. |
2005 |
Arch. Dis. Child. |
pmid:15851442
|
Hofman T et al. |
Tacrolimus ointment does not affect the immediate response to vaccination, the generation of immune memory, or humoral and cell-mediated immunity in children. |
2006 |
Arch. Dis. Child. |
pmid:16798785
|
Lancia P et al. |
Choosing the right dose of tacrolimus. |
2015 |
Arch. Dis. Child. |
pmid:25416736
|
Campo JV et al. |
Tacrolimus toxic reaction associated with the use of nefazodone: paroxetine as an alternative agent. |
1998 |
Arch. Gen. Psychiatry |
pmid:9819077
|
Lenz O and Contreras G |
Treatment options for severe lupus nephritis. |
2004 Sep-Oct |
Arch. Immunol. Ther. Exp. (Warsz.) |
pmid:15507877
|
Nowaczyk M et al. |
2-Chlorodeoxyadenosine: lack of synergism with cyclosporine A and tacrolimus (FK 506). |
1995 |
Arch. Immunol. Ther. Exp. (Warsz.) |
pmid:8744655
|
GarcÃa-Roca P et al. |
CYP3A5 polymorphism in Mexican renal transplant recipients and its association with tacrolimus dosing. |
2012 |
Arch. Med. Res. |
pmid:22704849
|
Saner FH et al. |
Severe neurological events following liver transplantation. |
2007 |
Arch. Med. Res. |
pmid:17174727
|
Horne SM and Young KD |
Escherichia coli and other species of the Enterobacteriaceae encode a protein similar to the family of Mip-like FK506-binding proteins. |
1995 |
Arch. Microbiol. |
pmid:7540828
|
Orange D et al. |
Cellular immune suppression in paraneoplastic neurologic syndromes targeting intracellular antigens. |
2012 |
Arch. Neurol. |
pmid:22566506
|
Parashos SA et al. |
Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience. |
2009 |
Arch. Neurol. |
pmid:19597081
|
Liang L et al. |
Long-term outcomes of keratolimbal allograft for total limbal stem cell deficiency using combined immunosuppressive agents and correction of ocular surface deficits. |
2009 |
Arch. Ophthalmol. |
pmid:19901207
|
Murphy CC et al. |
Cyclosporine vs tacrolimus therapy for posterior and intermediate uveitis. |
2005 |
Arch. Ophthalmol. |
pmid:15883282
|
Okada AA |
Noninfectious uveitis: a scarcity of randomized clinical trials. |
2005 |
Arch. Ophthalmol. |
pmid:15883289
|
John SS et al. |
Chronic localized fibrosing vasculitis of the eyelid. |
2009 |
Arch. Ophthalmol. |
pmid:19822864
|
Moura Penteado LA et al. |
Evaluation of the effect of tacrolimus on periodontitis induced in rats. |
2017 |
Arch. Oral Biol. |
pmid:28399470
|
Gürkan A et al. |
Alpha 2 integrin gene (ITGA2) polymorphism in renal transplant recipients with and without drug induced gingival overgrowth. |
2014 |
Arch. Oral Biol. |
pmid:24581850
|
Gürkan A et al. |
Gingival crevicular fluid transforming growth factor-beta1 in cyclosporine and tacrolimus treated renal transplant patients without gingival overgrowth. |
2008 |
Arch. Oral Biol. |
pmid:18342291
|
Guimarães MR et al. |
Protective effects of Tacrolimus, a calcineurin inhibitor, in experimental periodontitis in rats. |
2007 |
Arch. Oral Biol. |
pmid:17367747
|
Cota LO et al. |
Gingival overgrowth in cyclosporine, tacrolimus, or sirolimus-based immunosuppressive regimens and the single nucleotide IL-6 (-174 G/C) gene polymorphism. |
2010 |
Arch. Oral Biol. |
pmid:20430366
|
Emingil G et al. |
GCF and serum myeloperoxidase and matrix metalloproteinase-13 levels in renal transplant patients. |
2010 |
Arch. Oral Biol. |
pmid:20637451
|
Türkoğlu O et al. |
Are antimicrobial peptides related to cyclosporine A-induced gingival overgrowth? |
2015 |
Arch. Oral Biol. |
pmid:25555253
|
Deschler DG et al. |
Posttransplantation lymphoproliferative disorder in patients under primary tacrolimus (FK 506) immunosuppression. |
1995 |
Arch. Otolaryngol. Head Neck Surg. |
pmid:7544136
|
Etzell JE and Wang E |
Acquired Pelger-Huët anomaly in association with concomitant tacrolimus and mycophenolate mofetil in a liver transplant patient: a case report and review of the literature. |
2006 |
Arch. Pathol. Lab. Med. |
pmid:16390246
|
DiGiuseppe JA et al. |
Tacrolimus-related posttransplant lymphoproliferative disorder presenting as autoimmune hemolytic anemia. |
1996 |
Arch. Pathol. Lab. Med. |
pmid:8629906
|
Steele BW et al. |
A longitudinal replicate study of immunosuppressive drugs: a College of American Pathologists study. |
2003 |
Arch. Pathol. Lab. Med. |
pmid:12653570
|
Wang S et al. |
A fast and simple high-performance liquid chromatography/mass spectrometry method for simultaneous measurement of whole blood tacrolimus and sirolimus. |
2005 |
Arch. Pathol. Lab. Med. |
pmid:15859639
|
Gorgan M et al. |
Pulmonary hemorrhage with capillaritis secondary to mycophenolate mofetil in a heart-transplant patient. |
2013 |
Arch. Pathol. Lab. Med. |
pmid:24168511
|
Papadea C and Lage JM |
Immunosuppressants testing in transplantation. |
2004 |
Arch. Pathol. Lab. Med. |
pmid:15578873
|
Linder MW and Elin RJ |
Implications of methodologic bias for therapeutic drug monitoring. |
1999 |
Arch. Pathol. Lab. Med. |
pmid:10506447
|
Chung Y and Cho H |
Preparation of highly water soluble tacrolimus derivatives: poly(ethylene glycol) esters as potential prodrugs. |
2004 |
Arch. Pharm. Res. |
pmid:15460452
|
Kwon M et al. |
Bioequivalence of tacrolimus formulations with different dynamic solubility and in-vitro dissolution profiles. |
2015 |
Arch. Pharm. Res. |
pmid:24627339
|
Park YJ et al. |
Physicochemical characterization of tacrolimus-loaded solid dispersion with sodium carboxylmethyl cellulose and sodium lauryl sulfate. |
2009 |
Arch. Pharm. Res. |
pmid:19557367
|
Seo YG et al. |
Preparation and pharmaceutical evaluation of new tacrolimus-loaded solid self-emulsifying drug delivery system. |
2015 |
Arch. Pharm. Res. |
pmid:25134927
|
Park JS et al. |
A rapid and sensitive method to determine tacrolimus in rat whole blood using liquid-liquid extraction with mild temperature ultrasonication and LC-MS/MS. |
2016 |
Arch. Pharm. Res. |
pmid:26589688
|
Choi D and Cho H |
Effect of tacrolimus derivatives on immunosuppression. |
2009 |
Arch. Pharm. Res. |
pmid:19407973
|
Choi D et al. |
Effects of water-soluble tacrolimus-PEG conjugate on insulin-dependent diabetes mellitus and systemic lupus erythematosus. |
2011 |
Arch. Pharm. Res. |
pmid:21910052
|
Hüser N et al. |
Graft preconditioning with low-dose tacrolimus (FK506) and nitric oxide inhibitor aminoguanidine (AGH) reduces ischemia/reperfusion injury after liver transplantation in the rat. |
2009 |
Arch. Pharm. Res. |
pmid:19280151
|
Ellouk-Achard S et al. |
Implication of CYP 3A in the toxicity of cyclosporin G (CsG), cyclosporin A (CsA) and FK506 on rat hepatocytes in primary culture. |
1997 |
Arch. Toxicol. |
pmid:9209689
|
Aam BB and Fonnum F |
Carbon black particles increase reactive oxygen species formation in rat alveolar macrophages in vitro. |
2007 |
Arch. Toxicol. |
pmid:17119925
|
Kafert-Kasting S et al. |
Safety assessment of intraportal liver cell application in New Zealand white rabbits under GLP conditions. |
2012 |
Arch. Toxicol. |
pmid:22532025
|
Massicot F et al. |
Modulation of energy status and cytotoxicity induced by FK506 and cyclosporin A in a renal epithelial cell line. |
1997 |
Arch. Toxicol. |
pmid:9248632
|
Kimura Y et al. |
Profiling the immunotoxicity of chemicals based on in vitro evaluation by a combination of the Multi-ImmunoTox assay and the IL-8 Luc assay. |
2018 |
Arch. Toxicol. |
pmid:29594315
|
Vandenbussche C et al. |
Tacrolimus-induced nephrotoxicity in mice is associated with microRNA deregulation. |
2018 |
Arch. Toxicol. |
pmid:29362864
|
Ellouk-Achard S et al. |
FK506 (Tacrolimus) decreases the cytotoxicity of cyclosporin A in rat hepatocytes in primary culture: implication of CYP3A induction. |
1998 |
Arch. Toxicol. |
pmid:9630010
|
Schaap MM et al. |
A novel toxicogenomics-based approach to categorize (non-)genotoxic carcinogens. |
2015 |
Arch. Toxicol. |
pmid:25270620
|
Briggs CJ et al. |
Comparison of the effect of FK506 and cyclosporin A on virus production in H9 cells chronically and newly infected by HIV-1. |
1999 |
Arch. Virol. |
pmid:10603169
|
Minder D et al. |
Immunophilins and HIV-1 infection. |
2002 |
Arch. Virol. |
pmid:12181673
|
Ebihara N |
[New strategy in the treatment of vernal keratoconjunctivitis by calcineurin inhibitor eye drops]. |
2010 |
Arerugi |
pmid:21119297
|
Akutsu I et al. |
[Inhibitory effect of inhaled FK-506 on increased bronchial responsiveness and eosinophil infiltration in the airway mucosa]. |
1992 |
Arerugi |
pmid:1377905
|